{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:57:56Z","timestamp":1770472676810,"version":"3.49.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1991]]},"DOI":"10.1093\/oxfordjournals.bmb.a072464","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T09:12:12Z","timestamp":1486113132000},"page":"87-98","source":"Crossref","is-referenced-by-count":346,"title":["Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers"],"prefix":"10.1093","volume":"47","author":[{"given":"W J","family":"Gullick","sequence":"first","affiliation":[]}],"member":"286","published-online":{"date-parts":[[1991]]},"container-title":["British Medical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bmb\/article-pdf\/47\/1\/87\/7285041\/47-1-87.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T17:43:06Z","timestamp":1503423786000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bmb\/article\/392216\/Prevalence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1991]]},"published-print":{"date-parts":[[1991]]}},"URL":"https:\/\/doi.org\/10.1093\/oxfordjournals.bmb.a072464","relation":{},"ISSN":["1471-8391","0007-1420"],"issn-type":[{"value":"1471-8391","type":"electronic"},{"value":"0007-1420","type":"print"}],"subject":[],"published":{"date-parts":[[1991]]}}}